172 RIGOSERTIB, A NOVEL RAS INHIBITOR, OVERCOMES AZACITIDINE RESISTANCE IN ACUTE MYELOID LEUKEMIA CELL LINES. Issue 1 (April 2015) - Cosenza, S.